CN1183929C - Medicine for curing prolapse of lumbar intervertebral disc and its preparation method - Google Patents

Medicine for curing prolapse of lumbar intervertebral disc and its preparation method Download PDF

Info

Publication number
CN1183929C
CN1183929C CNB011235314A CN01123531A CN1183929C CN 1183929 C CN1183929 C CN 1183929C CN B011235314 A CNB011235314 A CN B011235314A CN 01123531 A CN01123531 A CN 01123531A CN 1183929 C CN1183929 C CN 1183929C
Authority
CN
China
Prior art keywords
kilograms
medicine
radix
lumbar intervertebral
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011235314A
Other languages
Chinese (zh)
Other versions
CN1399977A (en
Inventor
董秀奇
耿鹏举
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011235314A priority Critical patent/CN1183929C/en
Publication of CN1399977A publication Critical patent/CN1399977A/en
Application granted granted Critical
Publication of CN1183929C publication Critical patent/CN1183929C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a medicine for curing the protrusion of lumbar intervertebral disk and a preparation method thereof, which is prepared from Chinese medicinal herbs of angelica, dragon blood, frankincense, myrrh, Radix Notoginseng, radix dipsaci from Sichuan of China, rhizoma drynariae, Fructus Chaenomelis, Su ground beetle, pyritum, semen persicae, Herba Artemisiae Anomalae, Bischofia polycarpa, dried rhizomeof rehamannia, moschus, grilled nux vomica, saffron, safflower, borneol, etc. according to scientific formula proportion. The present invention has the simple preparation method and convenient administration, and the medicine can treat the cataplasia and herniated macleos polposus tissues without sticking fibrous rings and cartilage endplate, relieve the oppression for the nerves, and eliminate the lumbar intervertebral disk symptoms. The present invention has the function that mucopolysaccharide protein or collagen, and protruding nucleus pulposus can be decomposed, shrunken, softened and absorbed by chymopapain with functions of activating blood, promoting menstruation and dissipating blood stasis.

Description

A kind of medicine for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof
The present invention relates to a kind of medicine for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof, is the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically exactly, belongs to the new drug technology of preparing.
Prolapse of lumbar intervertebral disc is the higher difficult disease of world today's osteopathia sickness rate, bring a lot of inconvenience to the patient, the lighter's pain unbearably, weight person is unable to leave the bed, and the patient is lived among the misery all day, though this sick method of multiple treatment is arranged at present, but unsatisfactory curative effect, medication can not be effected a radical cure this disease, and the operative treatment patient is not only painful, expense is high, and sequela is more.
A kind of medicine for the treatment of prolapse of lumbar intervertebral disc of the present invention and preparation method thereof, its objective is: this medication preparation is simple and can effectively treat prolapse of lumbar intervertebral disc, focus on regression, outstanding nucleus pulposus, and not sticking and fibrous ring and cartilage endplate, to reach the compressing that alleviates nerve root, and the disease of lumbar intervertebral disc is disappeared, obtain curing and having no side effect.
A kind of medicine for the treatment of prolapse of lumbar intervertebral disc of the present invention, its composition and proportioning are as follows: weight: percentage ratio
Radix Angelicae Sinensis 3.4%-4.6% Sanguis Draxonis 10%-25%
Olibanum 3.4%-4.6% Myrrha 3.4%-4.6%
Radix Notoginseng 3.4%-4.6% Radix Dipsaci 3.4%-5.6%
Drynaria baronii 2.8%-5.6% Fructus Chaenomelis 3.4%-4.6%
SUTUCHONG 3.4%-5.6% Pyritum 3.4%-4.6%
Semen Persicae 3.4%-4.6% JINU 3.4%-4.6%
Ramulus et Folium Bischofiae Javanicae 3.4%-4.6% Radix Rehmanniae 3.4%-7.5%
Moschus 0.2%-0.5% Semen Strychni (processed) 2%-4%
Stigma Croci 3.4%-4.6% Flos Carthami 10%-25%
Borneolum Syntheticum 2%-4%
A kind of preparation method for the treatment of the medicine of prolapse of lumbar intervertebral disc of the present invention is: 120 order powder are dried, are ground into to above-mentioned each component respectively, measure respectively according to the above ratio, mix, make powder respectively, honeyed pill, the watered pill all can.
A kind of medicine for the treatment of prolapse of lumbar intervertebral disc of the present invention and preparation method thereof, its advantage is: preparation method is simple, and medicine is succinct, and taking convenience has no side effect, and can thoroughly effect a radical cure this pertinacious disease.
A kind of medicine for the treatment of prolapse of lumbar intervertebral disc of the present invention, in the clinical trial in 3 years, existing 1000 many cases patients obtain recovery from illness, determined curative effect, cure rate reaches 92%, and effective percentage reaches 98%.
The present invention's medicine is with the Chinese prescription of rational proportion, focus on the outstanding nucleus pulposus of regression with medicine, and not sticking and fibrous ring and cartilage endplate, under the effect of tying-in medicine, go into marrow to form the chymopapain of chemistry, in addition promoting blood circulation to restore menstrual flow, the effect of blood stasis dispelling, and making the mucopolysaccharide albumen of vertebra dish or collagen protein reach outstanding vertebral pulp cracking, atrophy, softening absorbs to reach fully and cures.
Prolapse of lumbar intervertebral disc is how with bulging, the pathogenesis deviate from, the disease type of prolapse of lumbar intervertebral disc: one, arthralgia due to wind-cold dampness; Two, blood stasis type; Three, kidney deficiency; Four, caused by liver and kidney deficiency type.Also have in addition that senile osteoporosis is caused to move back shape and sexually revise and caused.
The outstanding of lumbar intervertebral disc mainly is that mucopolysaccharide albumen or collagen protein are formed, unnecessary vertebral pulp compressing nervus centralis root occurs and cause the appearance of various diseases, so the mechanism of action of medicine of the present invention utilizes chymopapain to destroy its mucopolysaccharide albumen or collagen protein exactly, impel the vertebral pulp cracking, atrophy and reach the purpose of healing.
In the proportioning of medicine of the present invention, utilize the contained active ingredient of each component, cooperatively interact, complement each other prescription science, rigorous.
Wherein: Chinese angelica blood supplementing and blood, menstruction regulating and pain relieving, chemical analysis contain volatile oil, butylidene phenol and dihydro acid phthalic anhydride, make the inferior pentanone of carboxyl benzene.
Sanguis Draxonis: the main dissipation stasis of blood, the key medicine of tissue regeneration promoting blood, marrow and blood are gone in pain relieving, and resinous gel is former;
Myrrha: promoting blood circulation and stopping pain, contain α and β heerabomyrrholic acid, contain r Myrrha phenol; Cinene;
Olibanum: resinous volatile oil, contain the gluing shell of α, β-boswellic acid and the Radix Astragali, analgesic therapy, coagulation of QI-blood;
Fructus Chaenomelis: contain Saponin, two kinds of curdled milk protease increase the blood capillary drag;
Drynaria baronii: invigorating kidney, promoting blood circulation, lumbago, rheumatic arthralgia master bone;
JINU: alcohol coagulates enzyme, improves the blood supply function;
SUTUCHONG: contain protease, the reuniting the fractured tendons and bones that relaxes, blood stasis removing subtracts pain;
Ramulus et Folium Bischofiae Javanicae: moisture Siberian cocklebur alkene and ocimene tannin, the glue property of overflowing is strong;
Flos Carthami: contain 15 α, 20 beta-hydroxies-△ 4-carboxylic alkene-3-ketolase;
Semen Strychni: contain colubrine, alkali strychnine, the reflection function of excited spinal cord;
Semen Persicae: blood circulation promoting and blood stasis dispelling contains volatile oil, seborrhea glue protein enzyme etc.
In proportioning because the effect that added the alcoholic acid promoter of acetic acid, oral after owing under the effect of pepsic facilitation and alkene, form chymopapain.
The specific embodiment:
After following each component dried respectively, respectively take by weighing the raw material kilogram after being ground into 120 order powder
Radix Angelicae Sinensis 3.5 Sanguis Draxonis 20 Olibanums 3.5 Myrrhas 3.5
Radix Notoginseng 3.5 Radix Dipsaci 4.5 drynaria baroniis 3.5 Fructus Chaenomeliss 3.5
SUTUCHONG 4.5 Pyritums 4.5 Semen Persicaes 4.5 JINU 4.5
Ramulus et Folium Bischofiae Javanicae 4.5 Radix Rehmanniae 6.5 Moschus 0.3 Semen Strychni (processed) 2.5
Stigma Croci 3.2 Flos Carthamis 17 Borneolum Syntheticums 2.5
After mixing in proportion, refined honey becomes ball again, and ball weighs 15 grams.
Medicine of the present invention is oral medicine, obeys a ball at every turn, and service once every day sooner or later, and yellow wine takes, 75 days course of treatment.
When taking medicine of the present invention, please note:
1, avoids eating anything raw or cold.
2, pain occurred at the nearly 3-4 of period in a medicine days and add reinfection, this is because due to the vertebral pulp cracking atrophy, is the good phenomenon that reaches recovery from illness in the treatment.
3, few patient plays erythema after medication, the external Folium Artemisiae Argyi, and the Fructus Kochiae is fried in shallow oil the i.e. disappearance that soup is washed.

Claims (2)

1, a kind of medicine for the treatment of prolapse of lumbar intervertebral disc, it is characterized in that: its component and proportioning are: percentage by weight
Radix Angelicae Sinensis 3.4%-4.6% Sanguis Draxonis 10%-25%
Olibanum 3.4%-4.6% Myrrha 3.4%-4.6%
Radix Notoginseng 3.4%-4.6% Radix Dipsaci 3.4%-5.6%
Drynaria baronii 2.8%-5.6% Fructus Chaenomelis 3.4%-4.6%
SUTUCHONG 3.4%-5.6% Pyritum 3.4%-4.6%
Semen Persicae 3.4%-4.6% JINU 3.4%-4.6%
Ramulus et Folium Bischofiae Javanicae 3.4%-4.6% Radix Rehmanniae 3.4%-7.5%
Moschus 0.2%-0.5% Semen Strychni (processed) 2%-4%
Stigma Croci 3.4%-4.6% Flos Carthami 10%-25%
Borneolum Syntheticum 2%-4%.
2, a kind of preparation method for the treatment of the medicine of prolapse of lumbar intervertebral disc, it is characterized in that: this preparation method is: with 3.5 kilograms of Radix Angelicae Sinensis, 20 kilograms of Sanguis Draxonis, 3.5 kilograms of Olibanums, 3.5 kilograms of Myrrhas, 3.5 kilograms of Radix Notoginsengs, 4.5 kilograms of Radix Dipsaci, 3.5 kilograms of drynaria baroniis, 3.5 kilograms of Fructus Chaenomeliss, 4.5 kilograms of SUTUCHONGs, 4.5 kilograms of Pyritums, 4.5 kilograms in Semen Persicae, 4.5 kilograms of JINU, 4.5 kilograms of Ramulus et Folium Bischofiae Javanicae, 6.5 kilograms in the Radix Rehmanniae, 0.3 kilogram in Moschus, 2.5 kilograms of Semen Strychni (processed), 3.2 kilograms of Stigma Crocis, 17 kilograms on Flos Carthami, 2.5 kilograms of Borneolum Syntheticums, oven dry respectively, be ground into 120 order powder, measure respectively by fixed mixing ratio weight, mix, make powder, honeyed pill, ball weighs 15 grams.
CNB011235314A 2001-07-30 2001-07-30 Medicine for curing prolapse of lumbar intervertebral disc and its preparation method Expired - Fee Related CN1183929C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011235314A CN1183929C (en) 2001-07-30 2001-07-30 Medicine for curing prolapse of lumbar intervertebral disc and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011235314A CN1183929C (en) 2001-07-30 2001-07-30 Medicine for curing prolapse of lumbar intervertebral disc and its preparation method

Publications (2)

Publication Number Publication Date
CN1399977A CN1399977A (en) 2003-03-05
CN1183929C true CN1183929C (en) 2005-01-12

Family

ID=4665133

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011235314A Expired - Fee Related CN1183929C (en) 2001-07-30 2001-07-30 Medicine for curing prolapse of lumbar intervertebral disc and its preparation method

Country Status (1)

Country Link
CN (1) CN1183929C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315526C (en) * 2005-08-11 2007-05-16 葛小平 Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny
CN105535375A (en) * 2015-12-18 2016-05-04 高鹏飞 Traditional Chinese medicine for treatment of liver-kidney deficient-type lumbar intervertebral disc protrusion and preparation method thereof

Also Published As

Publication number Publication date
CN1399977A (en) 2003-03-05

Similar Documents

Publication Publication Date Title
CN1333025A (en) Medicine for treating bone injury
CN1272066C (en) Medicinal composition for relieving itching
CN1175867C (en) Chinese medicine capsule for treating rbeumatism and protrusion of lumber interverterbral disc
CN1183929C (en) Medicine for curing prolapse of lumbar intervertebral disc and its preparation method
CN1314441C (en) Plaster for relaxing the muscles and joints and its prepn process
CN1055004C (en) Enternal use adhesive plaster for treatment of rheumatism
CN1247238C (en) Chinese medicine ointment preparation for curing hyperosteogeny, pain and numbness and its production method
CN1111046C (en) Chinese medicine preparation for curing postpartum disease of woman
CN1059327C (en) Inflammation diminishing and asthma stopping cream
CN1631430A (en) Chinese medicinal ointment for treating bone diseases
CN1058189C (en) External- and thermal-mounted trauma medicinal powder bag
CN1114439C (en) Medicine for treating dermatopathy and preparing process thereof
CN1212148C (en) External plaster of sea horse and soft-shelled turtle
CN1236798C (en) External medicine for treating bone tuberculosis
CN1055231C (en) Medicine for treating hyperosteogeny disease and preparing process thereof
CN1298371C (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN1286494C (en) Ointment for treating fracture and injury
CN1241587C (en) Chinese medicinal preparation for treating gynopathy
CN1966021A (en) Bone-setting pill
CN1814122A (en) Medicine for treating osteoporosis and preparing method
CN1141113C (en) Chinese patent medicine for curing peptic ulcer
CN1073433C (en) Medicine for psoriasis and preparing method thereof
CN1082378C (en) Externally-used arthralgia treating medicine and its preparation
CN1147313C (en) Orally applied medicine 'Gukangwang' for treating arthropathy and its preparing process
CN1223369C (en) Osteoproliferation medicine and preparing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050112

Termination date: 20090831